Join
Live feed
·
INSIDERFilingvia Quantisnow
Zynerba Pharmaceuticals Inc. logo

SEC Form 4: Anido Armando was granted 45,406 shares and covered exercise/tax liability with 12,547 shares, increasing direct ownership by 4% to 889,805 units to satisfy withholding tax

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ZYNE (Zynerba Pharmaceuticals Inc.) and more on Quantisnow.

SEC Form 4: Anido Armando was granted 45,406 shares and covered exercise/tax liability with 12,547 shares, increasing direct ownership by 4% to 889,805 units to satisfy withholding tax | Quantisnow